Article info

Role of stenting in coronary revascularisation


  1. Dr AH Gershlick, Glenfield Hospital, Leicester LE3 9QP, UKagershlick{at}
View Full Text


Gershlick AH
Role of stenting in coronary revascularisation

Publication history

  • First published July 1, 2001.
Online issue publication 
July 01, 2001
  • Role of stenting in coronary revascularisation - AH Gershlick. Heart 2001;86:104-12.

    References for web version only

    1. Gandhi MM, Lampe F, Wood DA. Incidence of stable angina pectoris. Eur Heart J 1992;13:181- 9.
    2. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single vessel coronary artery disease. N Engl J Med 1992;326:10- 16.
    3. Anon. Coronary angioplasty versus medical therapy for angina: the second randomised intervention of angina (RITA-2) trial (RITA-2 trial participants). Lancet 1997;350:461- 8.
    4. Anon. Coronary angioplasty versus coronary artery bypass surgery: the randomized intervention treatment of angina (RITA) trial. Lancet 1993;341:573- 80.
    5. Gershlick AH, de Bono P. Restenosis after angioplasty. Br Heart J 1990;64:351- 3.
    6. Riessen R, Karsch KR. Cellular biology of restenosis. Interventional Cardiology Monitor 1995;2:29- 36.
    7. Dawkins K. WEST trial abstract.
    8. de Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC study). Eur Heart J 1998;19:1214- 23.
    9. Almagor Y, Feld S, Kiemeneij F, et al. First international new intravascular rigid-flex endovascular stent study (FINESS): clinical and angiographic results after elective and urgent stent implantation. The FINESS trial investigators. J Am Coll Cardiol 1997;30:847- 54.
    10. Rodriguez A, Ayala F, Bernadi V, et al. Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long term follow up results J Am Coll Cardiol 1999;32:1351- 7.
    11. Serruys PW, Unger F, van Hout BA, et al. The ARTS (arterial revascularization therapies study): background, goals and methods. Int J Cardiovasc Intervent 1999;2:41- 50.
    12. Teirsten PS, Massuillo V, Jani S, et al. Catheter based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697- 703.
    13. Waksman R, White LR, Mehran R, et al. Two year follow-up after the coronary gamma radiation therapy for in-stent restenosis [abstract]. J Am Coll Cardiol 2000;35:10A (abstract 83-4).
    14. Leon MB, Tierstein PS, Moses JW, et al. GAMMA II trial of localised radiation therapy to inhibit restenosis after coronary stenting [abstract]. J Am Coll Cardiol 2000;35:50A (abstract 854).
    15. King SB, Williams DO, Chougule P, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty. Results of the beta energy restenosis trial (BERT). Circulation 1998;97:2025- 30.
    16. Newmann FJ, Gawaz M, Ott I, et al. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J Am Coll Cardiol 1996;27:15- 21.
    17. Tan KH, Henderson RA, Sulke N, et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting: ten years� experience [review]. Cathet Cardiovasc Diagn 1994;32:11- 17.
    18. Maiello L, Colombo A, Gianrossi R, et al. Favourable results of treatment of narrowed saphenous vein grafts with Palmaz-Schatz stent implantation. Eur Heart J 1994;15:1212- 16.
    19. Wong SC, Baim DS, Schatz RA. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz stent study group. J Am Coll Cardiol 1995;26:704- 12.
    20. Savage MP, Douglas JS, Fischman D, et al. Stent placement compared to balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740- 7.
    21. Baim D. Vein graft protection devices. The SAFER trial. Presented at the TCT Washington 2000.
    22. Buller CE, Dzavik V, Carere RG, et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the total occlusion study of Canada (TOSCA). Circulation 1999;100:236- 42.
    23. Marzocchi A, Ortolani P, Piovaccari G, et al. Coronary stenting for unstable angina: predictors of 30 day and long term clinical outcome. Coronary Artery Disease 1999;10:81- 8.
    24. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The primary angioplasty in myocardial infarction study group. N Engl J Med 1993;328:673- 9.
    25. O�Neill WW, Brodie BR, Ivanhoe R. Primary coronary angioplasty for acute myocardial infarction (the primary angioplasty registry). Am J Cardiol 1994;73:627- 34.
    26. Rodriguez A, Bernardi V, Fernandez M, et al. In hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 1998;81:1286- 91.
    27. Le May MR, Labinaz M, Marquis JF, et al. Late clinical and angiographic follow-up after stenting in evolving and recent myocardial infarction. Am Heart J 1998;135:714- 8.
    28. Le May MR, Labinaz M, Beanlands RS, et al. Usefulness of intracoronary stenting in acute myocardial infarction. Am J Cardiol 1996;78:148- 52.
    29. Anon. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. The EPIC investigation. N Engl J Med 1994;330:956- 61.
    30. Anon. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG investigators [see comments]. N Engl J Med 1997;336:1689- 96.
    31. Anon. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997;349:1429- 35.
    32. Anon. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting [see comments]. Lancet 1998;352:87- 92.
    33. Anon. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM-PLUS) study investigators [see comments] [published erratum appears in N Engl J Med 1998;339:415]. N Engl J Med 1998;338:1488- 97.
    34. Tcheng JE. Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. Am J Cardiol 1996;78:35- 40.
    35. Tcheng JE. Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to minimize platelet aggregation and coronary thrombosis. Am J Cardiol 1997;80:21B- 28B.
    36. Anon. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT trial investigators. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using Integrilin therapy [see comments]. N Engl J Med 1998;339:436- 43.
    37. Califf RM, Cohen EA, Buller CE, et al. High dose eptifibatide (Integrilin) in elective coronary stent implantation: results of the ESPRIT trial. Eur Heart J 2000;21:146.
    38. Simoons M, Wallentin L, Calliff RM. The GUSTO IV ACS study. Presented at the late breaking session ESC 2000.
    39. Doucet S, Schalig MJ, Hilton D, et al. The SISA study: a randomised comparison of balloon angioplasty and stent to prevent restenosis in small arteries [abstract]. J Am Coll Cardiol 2000;35 (suppl A):8.
    40. Koning R. Bestent in small arteries: the BESMART trial. J Am Coll Cardiol 2000;36:314- 31.
    41. Park SJ, Park SW, Hong MK, et al. Stenting of unprotected left main coronary artery stenoses: immediate and late outcome. J Am Coll Cardiol 1998;31:37- 42.
    42. Barragan P, Silvertri M, Simeoni JB, et al. Stenting in unprotected left main coronary artery: immediate and follow-up results [abstract]. Circulation 1996;94 (suppl I):I-672.
    43. Lefevre T, Louvard Y, Morice MC, et al. Stenting of bifurcation lesions: classification, treatments, and results. Cath Cardiovasc Intervent 2000;49:274�83.
    44. Hamon M, Richardeau Y, Lecluse E, et al. Director coronary stenting without balloon predilation in acute coronary syndromes. Am Heart J 1999;138:55- 8.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.